|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Derivative expense | |||||
| Unrealized foreign exchange loss (gain) | |||||
| Net gain (loss) on sales of trading securities | |||||
| Impairment loss on trading securities | |||||
| Changes in operating assets and liabilities: | |||||
| (Increase) decrease in prepaids | |||||
| Decrease (increase) in inventory | |||||
| Change in asset retirement obligation | |||||
| Increase in accounts payable and accrued liabilities | |||||
| Increase (decrease) in due to related parties | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Purchase of trading securities | |||||
| Proceeds on sale of trading securities | |||||
| Acquisition of equipment | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from private placement | |||||
| Proceeds from exercise of options and warrants | |||||
| Repurchase of capital stock | |||||
| Net cash used in financing activities | |||||
| Change in cash and cash equivalents and restricted cash during the year | |||||
| Cash and cash equivalents and restricted cash at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Restricted cash at end of year | |||||
| Cash and cash equivalents and restricted cash at end of year | |||||
| Reconciliation of Cash and Cash Equivalents and Restricted Cash | |||||
| Cash and cash equivalents at beginning of year | |||||
| Restricted cash at beginning of year | |||||
Loading...
